Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
DEL PRIS
SecurityDE:ABL / Abbott Laboratories
InstitutionHarbor Advisory Corp /ma/
Latest Disclosed Ownership24,316 shares
Latest Disclosed Value $ 2,496,524
Harbor Advisory Corp /ma/ reports 9.49% decrease in ownership of ABL / Abbott Laboratories

On May 7, 2026 - Harbor Advisory Corp /ma/ filed a 13F-HR form disclosing ownership of 24,316 shares of Abbott Laboratories (DE:ABL) valued at $2,159,747 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 26,866 shares of Abbott Laboratories. This represents a change in shares of -9.49% during the quarter. The current value of the position is $1,829,050 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 24,316 -2,550 -9.49 2,497 -25.85 0.7502
2026-02-06 2025-12-31 13F ABBOTT LABS COM 002824100 26,866 -1,970 -6.83 3,366 -12.84 1.0183
2025-11-12 2025-09-30 13F ABBOTT LABS COM 002824100 28,836 -1,909 -6.21 3,862 -7.63 1.1422
2025-08-12 2025-06-30 13F ABBOTT LABS COM 002824100 30,745 -1,598 -4.94 4,182 -2.54 1.3324
2025-05-13 2025-03-31 13F ABBOTT LABS COM 002824100 32,343 -690 -2.09 4,290 14.83 1.4401
2025-01-29 2024-12-31 13F ABBOTT LABS COM 002824100 33,033 -1,823 -5.23 3,736 -5.97 1.2273
2024-10-21 2024-09-30 13F ABBOTT LABS COM 002824100 34,856 -1,730 -4.73 3,974 4.53 1.2971
2024-07-25 2024-06-30 13F ABBOTT LABS COM 002824100 36,586 -450 -1.22 3,802 -9.69 1.3130
2024-04-29 2024-03-31 13F ABBOTT LABS COM 002824100 37,036 -308 -0.82 4,210 2.41 1.4329
2024-02-05 2023-12-31 13F ABBOTT LABS COM 002824100 37,344 -1,052 -2.74 4,110 10.54 1.4717
2023-10-27 2023-09-30 13F ABBOTT LABS COM 002824100 38,396 -360 -0.93 3,719 -12.00 1.3477
2023-08-03 2023-06-30 13F ABBOTT LABS COM 002824100 38,756 -125 -0.32 4,225 7.32 1.4917
2023-05-04 2023-03-31 13F ABBOTT LABS COM 002824100 38,881 224 0.58 3,937 -7.23 1.5032
2023-02-07 2022-12-31 13F ABBOTT LABS COM 002824100 38,657 -40 -0.10 4,244 13.35 1.7338
2022-10-31 2022-09-30 13F ABBOTT LABORATORIES COM 002824100 38,697 -148 -0.38 3,744 -11.30 1.7242
2022-08-01 2022-06-30 13F ABBOTT LABORATORIES COM 002824100 38,845 187 0.48 4,221 -7.76 1.8498
2022-05-13 2022-03-31 13F ABBOTT LABORATORIES COM 002824100 38,658 -1,000 -2.52 4,576 -18.01 1.8364
2022-02-07 2021-12-31 13F ABBOTT LABORATORIES COM 002824100 39,658 280 0.71 5,581 19.97 2.2636
2021-11-12 2021-09-30 13F ABBOTT LABORATORIES COM 002824100 39,378 0 0.00 4,652 1.91 2.0183
2021-08-04 2021-06-30 13F ABBOTT LABORATORIES COM 002824100 39,378 -935 -2.32 4,565 -5.51 2.0580
2021-05-13 2021-03-31 13F ABBOTT LABORATORIES COM 002824100 40,313 2,230 5.86 4,831 15.85 1.9204
2021-02-16 2020-12-31 13F ABBOTT LABORATORIES COM 002824100 38,083 9,396 32.75 4,170 33.57 2.2072
2020-10-26 2020-09-30 13F ABBOTT LABORATORIES COM 002824100 28,687 -295 -1.02 3,122 17.81 3.0612
2020-08-04 2020-06-30 13F ABBOTT LABORATORIES COM 002824100 28,982 -1,765 -5.74 2,650 9.23 2.6849
2020-04-28 2020-03-31 13F ABBOTT LABORATORIES COM 002824100 30,747 -395 -1.27 2,426 -10.31 2.6015
2020-02-05 2019-12-31 13F ABBOTT LABORATORIES COM 002824100 31,142 -986 -3.07 2,705 0.63 2.2505
2019-10-28 2019-09-30 13F ABBOTT LABORATORIES COM 002824100 32,128 -229 -0.71 2,688 -1.21 2.3462
2019-07-30 2019-06-30 13F ABBOTT LABORATORIES COM 002824100 32,357 -150 -0.46 2,721 4.69 2.4021
2019-04-23 2019-03-31 13F ABBOTT LABORATORIES COM 002824100 32,507 -793 -2.38 2,599 7.89 2.3232
2019-02-05 2018-12-31 13F ABBOTT LABORATORIES COM 002824100 33,300 -571 -1.69 2,409 -3.06 2.3839
2018-10-17 2018-09-30 13F ABBOTT LABORATORIES COM 002824100 33,871 -80 -0.24 2,485 19.99 2.1516
2018-07-23 2018-06-30 13F ABBOTT LABORATORIES COM 002824100 33,951 -120 -0.35 2,071 1.42 1.8588
2018-05-07 2018-03-31 13F ABBOTT LABORATORIES COM 002824100 34,071 -737 -2.12 2,042 2.82 1.8709
2018-01-30 2017-12-31 13F ABBOTT LABORATORIES COM 002824100 34,808 34,808 1,986 1.8980
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.